Australian Regulatory Body Grants Approval for New COVID-19 Treatment

The logo of the Therapeutic Goods Administration is seen at a COVID-19 vaccines press conference in Canberra, Australia, on May 6, 2021. AAP Image/Lukas Coch

The Australian Therapeutic Goods and Drugs Administration (TGA) has granted provisional approval for the use of the drug tocilizumab in the treatment of COVID-19.

Sold under the brand name “ACTEMRA” and produced by Roche, the drug is already an approved treatment for arthritis and inflammatory conditions and is the fourth COVID-19 treatment to be given regulatory approval in Australia.